Aspirin in the prevention of cardiovascular disease: a review
10.19485/j.cnki.issn2096-5087.2024.04.007
- Author:
JIANG Yuchen
;
GAO Qian
- Publication Type:Journal Article
- Keywords:
aspirin;
cardiovascular disease;
primary prevention;
secondary prevention
- From:
Journal of Preventive Medicine
2024;36(4):304-307,313
- CountryChina
- Language:Chinese
-
Abstract:
Abstract:Aspirin (ASA) is widely used for primary and secondary prevention of cardiovascular disease (CVD), but its strategy of application is highly controversial. Meanwhile, in terms of ASA prevention strategies for CVD, countries around the world are different. The United States is becoming increasingly cautious, while the European Union tends to focus on the benefits of ASA clinical use. China is concerned about the effectiveness of ASA in preventing CVD in the elderly. This article reviews relevant literature published domestically and internationally from 2005 to 2024 for the application of ASA in CVD prevention, ASA prevention strategies for CVD in main countries and the application of ASA in special groups such as chronic disease patients, which provides a basis for improving ASA prevention strategies for CVD and standardizing clinical application of ASA in China.
- Full text:2024072408461335130阿司匹林预防心血管疾病研究进展.pdf
